Pharmaceutical Business review

GPRD, DrugLogic enter data license agreement

DrugLogic’s Qscan product monitors patient, adverse event, claims, outcomes and publicly available data sources.

As per the terms of the collaboration, GPRD will allow DrugLogic to format and code the GPRD database so that it can be analysed by Qscan’s statistical engines.

Analysis of data across multiple parameters such as condition, age, gender, family history, treatments, outcomes can be done by the users.

In addition, the online system provides differential analysis, which includes comparison of drugs and diagnosis, reaction and drugs for different demographics, of the GPRD data.